• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    DBM Global Inc. Announces Election of Mark Koolis as CFO

    1/6/25 4:35:26 PM ET
    $VATE
    Metal Fabrications
    Industrials
    Get the next $VATE alert in real time by email

    PHOENIX, Jan. 06, 2025 (GLOBE NEWSWIRE) -- DBM Global Inc. ("DBM") announces the election of new Chief Financial Officer (CFO) – Mark Koolis. Former CFO Michael R. Hill has taken a different position with DBM and has been elected as Vice President of Finance and will remain on the DBM Board of Directors. The other Officers will keep their current roles: James R. Roach – Chairman and CEO, Robert N. Waldrep – Vice President, and Scott D. Sherman – Vice President, General Counsel, and Secretary.

    Mr. Roach stated that "Mike Hill has served, with distinction, as CFO for DBM Global since 2000 and we are excited to have Mike continue in a different role with the Company." Mr. Roach added that "Mark Koolis has been working closely with Mike over the last two years and will be ready to hit the ground running as our new CFO."

    Mr. Koolis stated that "I am excited to step into the role of CFO and continue to work with the incredible team at DBM Global to contribute to the company's continued success."

    New CFO Biography:

    Mark Koolis

    Mark Koolis joined DBM in September 2021 as VP of Finance and Administration. Mr. Koolis was part of the May 2021 Banker Steel acquisition where he worked as Chief Financial Officer since 2019 and was previously CFO of NYCC, a subsidiary of Banker Steel, from 2016-2019. Prior to joining Banker Steel, Mr. Koolis worked at Hubbell Inc. in various senior financial roles. Mr. Koolis holds a BS in Business Administration and Masters of Science in Accounting from the University of Connecticut.

    About DBM Global Inc.

    DBM Global Inc. is focused on delivering world class, sustainable value to its clients through a highly collaborative portfolio of companies which provide better designs, more efficient construction, and superior asset management solutions. The Company offers integrated steel construction services from a single source and professional services which include design-assist, design-build, engineering, detailing, BIM co-ordination, steel modeling/detailing, fabrication, rebar detailing, advanced field erection, project management, and state-of-the-art steel management systems. Major market segments include commercial, healthcare, convention centers, stadiums, gaming and hospitality, mixed use and retail, industrial, public works, bridges, transportation, and international projects. The Company, which is headquartered in Phoenix, Arizona, has operations in United States, Australia, Canada, India, New Zealand, the Philippines, Singapore, Thailand and the United Kingdom.

    Contact:

    DBM Global Inc.

    Mark Koolis

    (602)257-7838

    [email protected]

    For additional information on DBM Global's majority shareholder, INNOVATE Corp. (NYSE:VATE), please visit http://www.innovatecorp.com or contact:  

    Investor Contact:

    Solebury Strategic Communications

    Anthony Rozmus

    (212) 235-2691

    Email: [email protected]

    Cautionary Statement Regarding Forward-Looking Statements

    Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995: This release contains, and certain oral statements made by our representatives from time to time may contain, forward-looking statements. Generally, forward-looking statements include information describing actions, events, results, strategies and expectations and are generally identifiable by use of the words "believes," "expects," "intends," "anticipates," "plans," "seeks," "estimates," "projects," "may," "will," "could," "might," or "continues" or similar expressions. The forward-looking statements in this press release include without limitation statements regarding our expectation regarding building shareholder value. Such statements are based on the beliefs and assumptions of DBM Global's management and the management of DBM Global's subsidiaries. The Company believes these judgments are reasonable, but you should understand that these statements are not guarantees of performance or results, and the Company's actual results could differ materially from those expressed or implied in the forward-looking statements due to a variety of important factors, both positive and negative, that may be revised or supplemented in subsequent reports on INNOVATE Corp.'s Forms 10-K, 10-Q and 8-K. These risks and other important factors discussed under the caption "Risk Factors" in INNOVATE's most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission ("SEC"), and other reports filed with the SEC could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release.

    You should not place undue reliance on forward-looking statements. All forward-looking statements attributable to DBM Global or persons acting on its behalf are expressly qualified in their entirety by the foregoing cautionary statements. All such statements speak only as of the date made, and DBM Global undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.



    Primary Logo

    Get the next $VATE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $VATE

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $VATE
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • INNOVATE Corp. Announces First Quarter 2025 Results

      - Infrastructure: DBM Global first quarter revenue of $264.9 million -- Life Sciences: MediBeacon® Transdermal GFR ("TGFR") System Received FDA Approval to Assess Kidney Function -- Spectrum: Expects commercial opportunities in datacasting to generate revenue by the end of the year - NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. ("INNOVATE" or the "Company") (NYSE:VATE) announced today its consolidated results for the first quarter. Financial Summary (in millions, except per share amounts)Three Months Ended March 31,  2025   2024  Increase / (Decrease)Revenue$274.2  $315.2  (13.0)%Net loss attributable to common stockholders and participating preferred stockholders$(24.8) $(

      5/6/25 4:05:39 PM ET
      $VATE
      Metal Fabrications
      Industrials
    • INNOVATE Corp. to Report First Quarter 2025 Results on May 6th

      NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE:VATE) ("INNOVATE" or the "Company") announced today that it will release its financial results for the first quarter 2025 on Tuesday, May 6, 2025, after market close. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 4:30 p.m. ET. Dial-in instructions for the conference call and the replay are outlined below. This conference call will also be broadcast live over the internet and can be accessed by all interested parties through INNOVATE's Investor Relations website at www.innovate-ir.com. To listen to the live call, please go to the "Investor

      4/16/25 4:05:39 PM ET
      $VATE
      Metal Fabrications
      Industrials
    • INNOVATE Corp. Announces Fourth Quarter and Full Year 2024 Results

      - Infrastructure: DBM Global fourth quarter revenue of $225.7 million -- Life Sciences: MediBeacon® Transdermal GFR ("TGFR") system received FDA approval to assess kidney function -- Spectrum: Broadcasting achieved double-digit revenue growth in the fourth quarter and full year 2024 - NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. ("INNOVATE" or the "Company") (NYSE:VATE) announced today its consolidated results for the fourth quarter. Financial Summary (in millions, except per share amounts)Three Months Ended December 31, Year Ended December 31,  2024   2023  Increase / (Decrease)  2024   2023  Increase / (Decrease)Revenue$236.6  $361.0  

      3/31/25 4:04:24 PM ET
      $VATE
      Metal Fabrications
      Industrials

    $VATE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Financial Officer Sena Michael J. covered exercise/tax liability with 5,355 shares, decreasing direct ownership by 4% to 123,893 units (SEC Form 4)

      4 - INNOVATE Corp. (0001006837) (Issuer)

      3/17/25 5:09:56 PM ET
      $VATE
      Metal Fabrications
      Industrials
    • Chief Financial Officer Sena Michael J. covered exercise/tax liability with 862 shares and was granted 12,946 shares, increasing direct ownership by 10% to 129,248 units (SEC Form 4)

      4 - INNOVATE Corp. (0001006837) (Issuer)

      3/13/25 5:19:12 PM ET
      $VATE
      Metal Fabrications
      Industrials
    • Director Glazer Avram A received a gift of 4,195,804 shares and gifted 4,195,804 shares, decreasing direct ownership by 99% to 37,621 units (SEC Form 4)

      4 - INNOVATE Corp. (0001006837) (Issuer)

      12/18/24 4:13:57 PM ET
      $VATE
      Metal Fabrications
      Industrials

    $VATE
    SEC Filings

    See more
    • SEC Form 10-Q filed by INNOVATE Corp.

      10-Q - INNOVATE Corp. (0001006837) (Filer)

      5/6/25 4:16:18 PM ET
      $VATE
      Metal Fabrications
      Industrials
    • INNOVATE Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - INNOVATE Corp. (0001006837) (Filer)

      5/6/25 4:09:09 PM ET
      $VATE
      Metal Fabrications
      Industrials
    • SEC Form DEFA14A filed by INNOVATE Corp.

      DEFA14A - INNOVATE Corp. (0001006837) (Filer)

      4/28/25 4:16:15 PM ET
      $VATE
      Metal Fabrications
      Industrials

    $VATE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by INNOVATE Corp.

      SC 13G/A - INNOVATE Corp. (0001006837) (Subject)

      11/13/24 9:30:32 PM ET
      $VATE
      Metal Fabrications
      Industrials
    • Amendment: SEC Form SC 13D/A filed by INNOVATE Corp.

      SC 13D/A - INNOVATE Corp. (0001006837) (Subject)

      6/21/24 7:05:53 PM ET
      $VATE
      Metal Fabrications
      Industrials
    • SEC Form SC 13D/A filed by INNOVATE Corp. (Amendment)

      SC 13D/A - INNOVATE Corp. (0001006837) (Subject)

      4/1/24 4:18:15 PM ET
      $VATE
      Metal Fabrications
      Industrials

    $VATE
    Financials

    Live finance-specific insights

    See more
    • INNOVATE Corp. Announces First Quarter 2025 Results

      - Infrastructure: DBM Global first quarter revenue of $264.9 million -- Life Sciences: MediBeacon® Transdermal GFR ("TGFR") System Received FDA Approval to Assess Kidney Function -- Spectrum: Expects commercial opportunities in datacasting to generate revenue by the end of the year - NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. ("INNOVATE" or the "Company") (NYSE:VATE) announced today its consolidated results for the first quarter. Financial Summary (in millions, except per share amounts)Three Months Ended March 31,  2025   2024  Increase / (Decrease)Revenue$274.2  $315.2  (13.0)%Net loss attributable to common stockholders and participating preferred stockholders$(24.8) $(

      5/6/25 4:05:39 PM ET
      $VATE
      Metal Fabrications
      Industrials
    • INNOVATE Corp. to Report First Quarter 2025 Results on May 6th

      NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE:VATE) ("INNOVATE" or the "Company") announced today that it will release its financial results for the first quarter 2025 on Tuesday, May 6, 2025, after market close. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 4:30 p.m. ET. Dial-in instructions for the conference call and the replay are outlined below. This conference call will also be broadcast live over the internet and can be accessed by all interested parties through INNOVATE's Investor Relations website at www.innovate-ir.com. To listen to the live call, please go to the "Investor

      4/16/25 4:05:39 PM ET
      $VATE
      Metal Fabrications
      Industrials
    • INNOVATE Corp. Announces Fourth Quarter and Full Year 2024 Results

      - Infrastructure: DBM Global fourth quarter revenue of $225.7 million -- Life Sciences: MediBeacon® Transdermal GFR ("TGFR") system received FDA approval to assess kidney function -- Spectrum: Broadcasting achieved double-digit revenue growth in the fourth quarter and full year 2024 - NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. ("INNOVATE" or the "Company") (NYSE:VATE) announced today its consolidated results for the fourth quarter. Financial Summary (in millions, except per share amounts)Three Months Ended December 31, Year Ended December 31,  2024   2023  Increase / (Decrease)  2024   2023  Increase / (Decrease)Revenue$236.6  $361.0  

      3/31/25 4:04:24 PM ET
      $VATE
      Metal Fabrications
      Industrials

    $VATE
    Leadership Updates

    Live Leadership Updates

    See more
    • MediBeacon Inc. Appoints Dr. Steve Miller as Chief Medical Officer

      MediBeacon expands management team as enrollment in Phase 3 study focused on kidney disease is completed ST. LOUIS, May 16, 2023 /PRNewswire/ -- MediBeacon Inc., a portfolio company within the Pansend Life Sciences segment of INNOVATE Corp. (NYSE:VATE), today announced the appointment of Dr. Steve Miller as chief medical officer. In this role, Dr. Miller will be focused on driving a range of clinical and strategic initiatives. Dr. Miller formerly served as executive vice president and chief clinical officer at Cigna, where he led the company's clinical policy, quality, and per

      5/16/23 7:00:00 AM ET
      $VATE
      Metal Fabrications
      Industrials
    • Catalent Appoints Joseph A. Ferraro as Senior Vice President, General Counsel, Chief Compliance Officer, and Secretary

      Catalent, Inc. (NYSE:CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced the appointment of Joseph A. Ferraro as Senior Vice President, General Counsel, Chief Compliance Officer, and Secretary. Mr. Ferraro will be responsible for managing Catalent's global legal and compliance operations. He will be based at the company's headquarters in Somerset, New Jersey, head up the company's Legal Leadership Team, and serve on its Executive Leadership Team, reporting directly to Catalent's Executive Vice President and Chief Administrative Officer, Steven Fasman. This press release features multimedia. View the full release here: https:/

      2/13/23 8:00:00 AM ET
      $CTLT
      $PSEC
      $VATE
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Finance: Consumer Services
      Finance
    • INNOVATE Corp. Announces Appointment of Amy Wilkinson to the Board of Directors

      NEW YORK, Aug. 02, 2022 (GLOBE NEWSWIRE) -- INNOVATE Corp. ("INNOVATE" or the "Company") (NYSE:VATE), today announced the appointment of Amy Wilkinson to fill the remaining vacancy on the INNOVATE Board of Directors. "Amy brings a unique blend of management expertise and global business and policy experience, and we are confident she will help guide us in our mission to drive shareholder value across our Infrastructure, Life Sciences and Spectrum operating segments," said Avie Glazer, Chairman of INNOVATE. "Amy's leadership and strategy consulting experience advising Fortune 500 companies will be a valuable addition to our Board," said Wayne Barr, Jr., Chief Executive Officer of INNOVATE

      8/2/22 4:15:00 PM ET
      $VATE
      Metal Fabrications
      Industrials

    $VATE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Interim CEO Voigt Paul bought $99,500 worth of shares (25,000 units at $3.98) (SEC Form 4)

      4 - INNOVATE Corp. (0001006837) (Issuer)

      11/21/24 4:49:08 PM ET
      $VATE
      Metal Fabrications
      Industrials
    • Interim CEO Voigt Paul bought $166,383 worth of shares (43,785 units at $3.80), increasing direct ownership by 26% to 211,655 units (SEC Form 4)

      4 - INNOVATE Corp. (0001006837) (Issuer)

      9/16/24 4:17:05 PM ET
      $VATE
      Metal Fabrications
      Industrials
    • Interim CEO Voigt Paul bought $106 worth of shares (176 units at $0.60), increasing direct ownership by 0.01% to 1,678,695 units (SEC Form 4)

      4 - INNOVATE Corp. (0001006837) (Issuer)

      6/17/24 4:36:10 PM ET
      $VATE
      Metal Fabrications
      Industrials